Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference2 articles.
1. Antigen specific T-cell responses against tumor antigens are controlled by regulatory T cells in patients with prostate cancer;Hadaschik;J Urol,2012
2. Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer;Ragde;J Urol,2004